CARDIOVASCULAR JOURNAL OF AFRICA • Volume 34, No 4, September/October 2023 AFRICA 259 both myocardial reperfusion/revascularisation and allergic reaction.20 Corticosteroids and antihistamines are beneficial for the alleviation of inflammation and are helpful for the reversal of coronary vasospasm in the type I variant.21 In patients with type II variants, treatment should be directed by ACS treatment guidelines, in addition to steroids and antihistaminics.22 The management of the type III variant would be much more complicated, even needing stent extraction when necessary.23 Conclusion The main lesson of this case is that high suspicion of Kounis syndrome is needed when there is an allergic history with cardiac symptomatology. Only with increased awareness of this entity can more prompt initiation of treatment be achieved. Although in the majority of patients, the onset of clinical symptoms and signs are within one hour of trigger exposure,5 it could also present as a subacute or even chronic course. Measuring serum cardiac enzymes and cardiac-specific troponins is helpful in determining the level of cardiac damage associated with allergic insults. Echocardiography and coronary angiography are also indispensable in measuring cardiac wall abnormalities and management of coronary stenosis. Perhaps Kounis syndrome has been overlooked and underdiagnosed in China and being more vigilant about this condition in clinical practice may not only improve patient care but also lead to the discovery of more causative factors in the future. References 1. Pfister CW, Plice SG. Acute myocardial infarction during a prolonged allergic reaction to penicillin. Am Heart J 1950; 40(6): 945–947. 2. Kounis NG. Coronary hypersensitivity disorder: the Kounis syndrome. Clin Ther 2013; 35(5): 563–571. 3. Kounis NG. Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management. Clin Chem Lab Med 2016; 54(10): 1545–1559. 4. Renda F, Landoni G, Trotta F, Piras D, Finco G, Felicetti P, et al. Kounis syndrome: An analysis of spontaneous reports from international pharmacovigilance database. Int J Cardiol 2016; 203: 217–220. 5. Abdelghany M, Subedi R, Shah S, Kozman H. Kounis syndrome: A review article on epidemiology, diagnostic findings, management and complications of allergic acute coronary syndrome. Int J Cardiol 2017; 232: 1-4. 6. Tan W, Cheng KL, Chen QX. Hypersensitivity to drug-eluting stent and stent thrombosis: Kounis or not Kounis syndrome? Chin Med J (Engl) 2009; 122(19): 2390–2393. 7. Gao J, Gao Y, Ma J. Cefuroxime-associated Kounis syndrome with unique peculiarity in perioperative prophylaxis. J Infect Public Health 2018; 11(6): 889–892. 8. Chang KL, Chen J, Yu J, Dou XL. Kounis syndrome leads to cardiogenic shock. Cardiovasc J Afr 2013; 24(9-10): e12–16. 9. Li J, Zheng J, Zhou Y, Liu X, Peng W. Acute coronary syndrome secondary to allergic coronary vasospasm (Kounis syndrome): a case series, follow-up and literature review. BMC Cardiovasc Disord 2018; 18(1): 42. 10. Wu H, Cao Y, Chang F, Zhang C, Hu Y, Liang L. Kounis syndrome induced by anisodamine: a case report. Int J Gen Med 2020; 13: 1523–1527. 11. Yang X, Feng X, Duan F, Wang Z, Raut MS, Swain B. Neostigmineinduced coronary spasm: Beware of Kounis syndrome. J Anaesthesiol Clin Pharmacol 2018; 34(1): 123–124. 12. Erxun K, Wei L, Shuying Q. Kounis syndrome caused by chronic autoimmune urticaria: a case report. J Emerg Med 2016; 50(1): 37–40. 13. Tang R, Sun JL. Acute myocardial infarction induced by anaphylaxis. Chin Med J (Engl) 2018; 131(10): 1251–1252. 14. Tan L, Li M, Lin Y. Safety concerns of traditional Chinese medicine injections used in Chinese children. Evid Based Complement Alternat Med 2019; 2019: 8310368. 15. Huang R, Cai Y, Yang L, Shangguan X, Ghose B, Tang S. Safety of traditional Chinese medicine injection based on spontaneous reporting system from 2014 to 2019 in Hubei Province, China. Sci Rep 2021; 11(1): 8875. 16. Li X, Thai S, Lu W, Sun S, Tang H, Zhai S, et al. Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database. Int J Clin Pharm 2018; 40(4): 921–927. 17. Wang J, Wang P, Wang X, Zheng Y, Xiao Y. Use and prescription of antibiotics in primary health care settings in China. J Am Med Assoc Intern Med 2014; 174(12): 1914–1920. 18. Ozdemir IH, Ozlek B, Ozen MB, Gunduz R, Bayturan O. Type 1 Kounis syndrome induced by inactivated SARS-COV-2 vaccine. J Emerg Med 2021; 61(4): e71–e76. 19. Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis 2021; 21(2): 181–192. 20. Cevik C, Nugent K, Shome GP, Kounis NG. Treatment of Kounis syndrome. Int J Cardiol 2010; 143(3): 223–226. 21. Koutsojannis CM, Mallioris CN, Kounis NG. Corticosteroids, Kounis syndrome and the treatment of refractory vasospastic angina. Circ J 2004; 68(8): 806; author reply: 7. 22. Dogan V, Mert GO, Biteker FS, Mert KU, Biteker M. Treatment of Kounis syndrome. Int J Cardiol 2015; 181: 133–134. 23. Atoui R, Mohammadi S, Shum-Tim D. Surgical extraction of occluded stents: when stenting becomes a problem. Interact Cardiovasc Thorac Surg 2009; 9(4): 736–738.
RkJQdWJsaXNoZXIy NDIzNzc=